Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
12/2013
12/27/2013WO2013190212A1 Method for producing chiral peptides
12/26/2013US20130345254 Cyclohexane substituted amino cyclopentane derivatives as useful ccr2 antagonists
12/26/2013US20130345179 Substituted tetracycline compounds for treatment of inflammatory skin disorders
12/25/2013EP2173707B1 Pleuromutilin derivatives and their use as antimicrobials
12/25/2013CN103467344A Method for recovering urea from tetracycline urea compound salt crystallization mother liquor and recycling urea
12/25/2013CN103467337A Preparation method of demethylation aureomycin hydrochloride
12/25/2013CN103467336A Synthesis process of doxycycline hydrochloride intermediate 11alpha-chlorinated methacycline
12/25/2013CN103467335A Method for synthesizing doxycycline hydrochloride intermediate alpha-6-deoxytetracycline based on hydrogenation of carbon-based rhodium catalyst
12/25/2013CN103467334A Synthesis method of N-(2-chloride)-propionyl-glutamine
12/25/2013CN103467333A Method for purifying L-glutamine from fermentation liquid through two-step crystallization
12/24/2013US8614346 Methods and compositions for preparation of amphetamine conjugates and salts thereof
12/24/2013US8614251 Crystalline form VI of agomelatine, preparation method and application thereof
12/24/2013US8614238 Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use
12/19/2013US20130336903 Personal Care Compositions Comprising a pH Tuneable Gellant and Methods of Using
12/18/2013EP2674415A1 Homo- and hetero-polyamino-acid derivatives of fullerene c60, method for producing same, and pharmaceutical compositions based on said derivatives
12/18/2013EP2445868B1 Biphenyl amides useful as p2x3 and/or p2x2/3 receptors modulators
12/18/2013EP1743015B1 Surfactant composition method for production thereof and cosmetic comprising said composition
12/18/2013CN103451931A Carbon fiber surface modifier, modified carbon fiber, composite material, and preparation methods thereof
12/17/2013US8609733 Sensory-specific local anesthesia and prolonged duration local anesthesia
12/12/2013WO2013185116A1 Lipids for therapeutic agent delivery formulations
12/12/2013WO2013182023A1 Carbon fiber surface modifier, modified carbon fiber, composite material and preparation methods therefor
12/12/2013CA2876148A1 Lipids for therapeutic agent delivery formulations
12/11/2013CN103435606A CDK2 and CSK3beta dual inhibitor and application thereof
12/11/2013CN103435514A Matrix metalloproteinase inhibitor and purpose thereof
12/11/2013CN102432495B Method for separating and concentrating L-theanine from glutaminase or glutamyl transpeptidase conversion liquid by membrane integration technology
12/11/2013CN102304056B 3-methyl-4-aryl-3-alkenyl-butyryl-pentafluoroaniline derivatives and preparation method thereof
12/11/2013CN102249833B Method for preparing chiral gamma-amino acid and derivatives thereof
12/11/2013CN102015626B 4-trimethylammonio-butyrates as CPT2 inhibitors
12/10/2013US8604083 Method for the treatment of metabolic disorders
12/10/2013CA2556940C Modulator
12/10/2013CA2552317C Hcv ns-3 serine protease inhibitors
12/05/2013WO2013180271A1 Prodrug of fluorine-containing amino acid
12/05/2013US20130324717 Copolymerizable methine and anthraquinone compounds and articles containing them
12/05/2013CA2875080A1 Prodrug of fluorine-containing amino acid
12/04/2013EP2668155A2 New aryl-benzocycloalkyl amide derivatives
12/04/2013CN103420868A Biquaternary ammonium salt-containing diamine or diol monomer, preparation method of monomer, water-based non-toxic antibacterial polyurethane emulsion prepared by monomer, and preparation method of emulsion
12/04/2013CN102093248B Method for preparing N-(2-Methylphenyl)-2-(propylamino)propa-namide
12/03/2013US8598148 Synthesis of tetracyclines and analogues thereof
12/03/2013CA2755650C Process for the preparation of triiodinated carboxylic aromatic derivatives
12/03/2013CA2530302C Novel aminobenzophenone compounds
12/03/2013CA2489590C Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
11/2013
11/28/2013US20130317110 Compound, kinesin spindle protein inhibitor, and application thereof
11/27/2013EP2665472A1 Compounds for treatment of heart failure
11/27/2013CN203307256U Synthesis stripper plant for preparing urea
11/27/2013CN103415502A Chelating agent precursors, fluids containing them, and their use
11/27/2013CN103408453A Insecticidal compounds
11/27/2013CN102675535B Branched polyacrylamide and preparation method thereof
11/21/2013WO2013172358A1 Functional compound, molecular assembly containing functional compound, composition containing molecular assembly, kit, and use of molecular assembly, composition or kit
11/21/2013US20130310459 Amide derivative, pest control agent containing the amide derivative, and use of the amide derivative
11/20/2013EP2468717B1 Heterocyclic Amide Compounds Useful as Kinase Inhibitors
11/20/2013EP1540037B1 Organic salts and their use as reagents in electrochemical reactions
11/19/2013US8586765 Process for the synthesis of 3-amino-3-cyclobuthylmethyl-2-hydroxypropionamide or salts thereof
11/19/2013US8586585 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
11/19/2013CA2786802C Composition for exterminating animal parasite comprising an aromatic carboxamide derivative and method thereof
11/19/2013CA2603030C Benzyloxypropylamine derivative
11/14/2013US20130303582 Compositions for prevention/prophylactic treatment of poison ivy dermatitis
11/14/2013US20130303568 Substituted 2-Aminoacetamides and the Use Thereof
11/14/2013US20130303545 Cyclopropylamine derivatives useful as lsd1 inhibitors
11/13/2013CN103391923A Benzamide derivatives as p2x7 receptor antagonists
11/13/2013CN103391920A Calcium-sensing receptor-active compounds
11/13/2013CN103387567A NEPT compound and preparation method and application thereof
11/13/2013CN103387512A Preparation method and intermediate of minocycline
11/13/2013CN103387511A Preparation method for sancycline
11/13/2013CN103387510A Synthesis method of beta-amino-alpha-hydroxycyclohexyl butyl aluminum hydrochloride
11/13/2013CN102516116B Low-osmotic-pressure triiodo-benzene compound contrast agent
11/13/2013CN102336681B Triiodobenzene compound contrast agent
11/13/2013CN102146048B Lacosamide intermediate compound and preparation method and application thereof
11/12/2013CA2601481C Process for the preparation of opioid modulators
11/07/2013WO2013165606A1 Modulators of the relaxin receptor 1
11/07/2013US20130296279 Substituted tetracyclines
11/06/2013CN103382160A Synthesis of iopamidol and preparation of iopamidol synthesis intermediate
11/06/2013CN102281861B Monoester of n-undecylenoyl phenylalanine and polyol, method for preparing same, and use of said esters as a skin lightening agent
11/06/2013CN102241604B Amino acid modified curcumin, synthesis method thereof, and application thereof
11/06/2013CN102020589B Tert-butyl carbamate derivative and preparation method and application thereof
11/06/2013CN101786971B Preparation process of doxycycline hydrochloride
11/05/2013US8575391 5-substituted-2-phenylamino benzamides as MEK inhibitors
11/05/2013US8575390 Branched succinimide dispersant compounds and methods of making the compounds
11/05/2013CA2672722C Methods of preparing substituted tetracyclines with transition metal-based chemistries
10/2013
10/31/2013WO2013161980A1 Cyclohexanediamide derivative and use thereof for medical purposes
10/31/2013US20130289124 Phenylcyclobutylamide derivatives and their stereoisomers, the preparation processes and uses thereof
10/31/2013US20130289122 Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
10/31/2013US20130289076 Cyclopropylamine inhibitors of oxidases
10/30/2013EP2655318A1 Desalination of a composition comprising a contrast agent
10/30/2013CN1989099B Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases
10/30/2013CN103380113A Amine-containing transfection reagents and methods for making and using same
10/30/2013CN102276498B Contrast medium for triiodobenzene compound
10/30/2013CN102153483B Axial chirality vicinal diamine compound and preparation method thereof
10/30/2013CN101679218B Crystalline minocycline base and processes for its preparation
10/24/2013WO2013157955A1 Geranyl geranyl acetone analogs and uses thereof
10/24/2013WO2013157926A1 Geranyl geranyl acetone analogs and uses thereof
10/24/2013US20130281705 Compounds for the treatment of metabolic disorders
10/24/2013US20130281394 Chemosensory Receptor Ligand-Based Therapies
10/24/2013US20130280305 Cationic lipid
10/23/2013CN103360277A Method for recrystallizing ubenimex
10/23/2013CN101823928B Clean production process for derivatives of para aminobenzoic acid by reactor coupled simulated moving bed
10/22/2013US8563736 Amide derivatives, process for preparation thereof and use thereof as insecticide
10/22/2013US8563615 Use of CI-994 and dinaline for the treatment of memory/cognition and anxiety disorders
10/22/2013US8563041 Therapeutic particles suitable for parenteral administration and methods of making and using same
10/17/2013US20130274249 Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
10/16/2013EP2649040A1 Process for homogeneously catalyzed, highly selective direct amination of primary alcohols with ammonia to primary amines with a high volume ratio of liquid phase to gas phase and/or high pressures
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 162